Albumin-dependent digoxin transfer in isolated perfused human placenta

Area of Science:

• Pharmacology
• Reproductive Biology
• Perinatal Medicine

Background:

• Digoxin transfer across the placenta is crucial for managing fetal cardiac conditions.
• Albumin, a major serum protein, influences drug transport.
• Understanding albumin's role is key to optimizing digoxin therapy during pregnancy.

Purpose of the Study:

• To investigate the effect of varying bovine serum albumin (BSA) concentrations on digoxin transfer in an isolated perfused human placental cotyledon model.
• To determine the optimal BSA concentration for digoxin transfer.

Main Methods:

• Isolated human placental cotyledons were perfused using M199 medium with varying BSA concentrations (1, 3, and 5 mg/ml).
• Digoxin was added to the maternal circulation, and its transfer to the fetal circulation was monitored over 3 hours.
• Digoxin levels were quantified using fluorescence polarization immunoassay (FPIA).

Main Results:

• No digoxin transfer was detected from the maternal to the fetal compartment at a BSA concentration of 1 mg/ml.
• Increasing BSA concentration led to a significant increase in digoxin transfer.
• A steady-state fetal digoxin level of 0.61 ± 0.19 ng/ml was achieved at 3 mg/ml BSA.

Conclusions:

• Maternal and fetal serum albumin concentrations critically influence digoxin transfer across the human placenta.
• An optimal albumin concentration of 3 mg/ml is identified for effective digoxin transfer.